
COMBINATION THERAPY FOR BENIGN PROSTATIC HYPERPLASIA (BPH).
Otajonov Odilbek Rozzoqberganovich , (Urgench branch of Tashkent Medical Academy)Abstract
Timely initiation of treatment of benign prostatic hyperplasia (BPH) with the combined drug duodart (which includes a double inhibitor of 5α-reductase - dutasteride and an α1a-adrenergic receptor blocker - tamsulosin hydrochloride) in patients with prostate cell proliferation stops, and then cell apoptosis begins. This leads to improved urination, a decrease in the volume of prostatic hyperplasia, an improvement in the quality of life of patients and the avoidance of surgery.
Keywords
Benign prostatic hyperplasia (BPH) is the most common disease in older men, which is based on the increasing infravesical obstruction caused by prostatic hyperplasia. The disease develops slowly and progresses with age.
References
European Association of Urology [internet]. Available from: http://uroweb.org/wp-content/uploads/EAU-Guidelines-Non-NeurogenicMale-LUTS-Guidelines-2016.
Wang X, Wang X, Li S, Meng Z, Liu T, Zhang X. Comparative effectiveness of oral drug therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and network meta-analysis. PLoS One, 2014 Sep 12, 9: e107593.
Reich O., Gratzke C., Bachmann A. et al. UrologySection of the Bavarian Working Group for Quality Assurance. Morbidity, mortality and early outcome of transurethral resection of the prostate: A prospective multicenter evaluation of 10,654 patients. J Urol. 2008; 180b(1):
Foley S.J. and Bailey D.M.: Microvascular density in prostatic hyperplasia. BJU Int, 85:70, 2000.
Mebust W.K., Holtgrewe H.L., Cockett A.T.K., Peters P.C. and Writing Committee: Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol, 141: 243, 1989.
Rakhimov BS, Mekhmanov MS, Bekchanov BG. Parallel algorithms for the creation of medical database. J Phys Conf Ser. 2021;1889(2):022090. doi:10.1088/1742-6596/1889/2/022090
Rakhimov BS, Rakhimova FB, Sobirova SK. Modeling database management systems in medicine. J Phys Conf Ser. 2021;1889(2):022028. doi:10.1088/1742-6596/1889/2/022028
Rakhimov B, Ismoilov O. Management systems for modeling medical database. In: ; 2022:060031. doi:10.1063/5.0089711
Rakhimov BS, Khalikova GT, Allaberganov OR, Saidov AB. Overview of graphic processor architectures in data base problems. In: ; 2022:020041. doi:10.1063/5.0092848
Allaberganov, O.R., Rakhimov, B.S., Sobirova, S.K., Rakhimova, F.B., Saidov, A.B. Problem for Medical System with Infinite Zone Potential in the Half Line AIP Conference Proceedings, 2022, 2647, 050025
RB Saidovich, SA Bakhtiyarovich, BB Farkhodovich, KDA Ugli, MMZ Qizi Analysis And Using of the Features Graphics Processors for Medical Problems Texas Journal of Medical Science 7, 105-110
Article Statistics
Downloads
Copyright License

This work is licensed under a Creative Commons Attribution 4.0 International License.